Rapaport, E.: Serum enzyme and isoenzymes in the diagnosis of acute myocardial infarction . Mod. Concepts Cardiovasc. Dis., 46: 43, 1977.
2.
Markert, C.L. : Lactate dehydrogenase isozymes: Dissociation and recombination of subunits. Science, 140: 1329, 1963 .
3.
Cohen, L., Djordjevich, J., Ormiste, V.: Serum lactic dehydrogenase isozyme patterns in cardiovascular and other diseases, with particular reference to acute myocardial infarction. J. Lab. Clin. Med., 61: 355, 1964.
4.
Shell, W.E., Kjekshus, J.K., Sobel, B.E.: Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J. Clin. Invest., 50: 2614, 1971 .
5.
Sobel, B.E., Bresnahan, G.F., Shell, W.E., et al.: Estimation of infarct size in man and its relation to prognosis . Circulation, 46: 640, 1972.
6.
Sobel, B.E., Roberts, R., Larson, K.B.: Estimation of infarct size from serum MB creatine phosphokinase activity: Applications and limitations. Am. J. Cardiol., 37: 474, 1976.
7.
Sobel, B.E., Markham, J., Roberts R.: Factors influencing enzymatic estimates of infarct size. Am. J. Cardiol., 39: 130, 1977.
8.
Roe, C.R.: Validity of estimating myocardial infarct size from serial measurements of enzyme activity in the serum. Clin. Chem., 23: 1807, 1977.
9.
Rosalki, S.B. : An improved procedure for serum creatine phosphokinase determination. J. Lab. Clin. Med., 69: 696, 1967.
10.
Oliver, I.T. : A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem. J., 61: 116, 1955.
11.
Takahashi, K., Ushikubo, S., Oimomi, H., et al.: Creatine phosphokinase isoenzymes of human heart muscle and skeletal muscle. Clin. Chem. Acta , 38: 285, 1972.
12.
Wacker, W.E.C. , Ulmer, D.D., Valee, B.L.: Metalloenzymes and myocardial infarction II. Malic and lactic dehydrogenase activities and zinc concentrations in serum . N. Engl. J. Med., 255: 449, 1956.
13.
Gay, R.J., McComb, R.B., Bowers, G.N.: Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactic dehydrogenase activity . Clin. Chem., 14: 740, 1968.
14.
Galen, R.S. , Reiffel, J.A., Gambino, R.: Diagnosis of acute myocardial infarction. Relative efficiency of serum enzyme and isoenzyme measurements. J. Am. Med. Assoc., 232: 145, 1975.
15.
Strauss, H.D. , Roberts, R.: Plasma MB creatine kinase activity and other conventional enzymes. Comparison in patients with chest pain and tachyarrhythmias . Arch. Int. Med., 140: 336, 1980.
16.
Vasudevan, G., Mercer, D.W., Varat, M.A.: Lactic dehydrogenase isoenzyme determination in the diagnosis of acute myocardial infarction. Circulation , 57: 1055, 1978.
17.
Sobel, B.E. , Shell, W.E.: Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation, 45(Suppl.): 97, 1972.
18.
Warbasse, J.R. , Wesley, J.E., Connolly, V., et al.: Lactic dehydrogenase isoenzymes after electroshock treatment of cardiac arrhythmias. Am. J. Cardiol. , 21: 496, 1968.
19.
Konttinen, A., Hupli, V., Louhija, A., et al.: Origin of elevated serum enzyme activities after direct current countershock. N. Engl. J. Med., 281: 231, 1969.
20.
Ehsani, A., Ewy, G.A., Sobel, B.E.: Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. Am. J. Cardiol., 37: 12, 1976.
Irvin, R.G. , Cobb, F.R., Roe, C.R.: Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch. Int. Med., 40: 329, 1980.
23.
Witteveen, S.A.G.T., Hemker, H.C., Hollaar, L. et al.: Quantitation of infarct size in man by means of plasma enzyme levels. Br. Heart J., 37: 795, 1975.
24.
Hjalmarson, A., Ariniego, R., Herlitz, J., et al.: Limitation of infarct size in man by the beta-1 blocker metoprolol. Circulation, 59,60(Abs.): 640, 1979.
